Detailed answers about HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED, including incorporation, status, business activity, and accounts information.
When was HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED founded?
HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED was officially incorporated on 17 September 2025 and is registered under company number 16725267. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED?
HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED do?
HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED's registered address?
The registered office address of HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED is UNIT 4, FISHERGREEN, RIPON, NORTH YORKSHIRE, ENGLAND, HG4 1NL. This is the official address filed with Companies House for legal and statutory correspondence.
Is HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED financially stable?
Financial accounts for HYPERBARIC OXYGEN THERAPY (RIPON) LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.